MedPath

Mount Sinai Hospital (Canada)

🇨🇦Canada
Ownership
Subsidiary
Employees
-
Market Cap
-
Website
http://www.mtsinai.on.ca

Use of a Calcium Channel Blocker to Prevent Premature Luteinizing Hormone Surges in Infertility Patients

Phase 2
Terminated
Conditions
Infertility
Interventions
Drug: Placebo
First Posted Date
2012-03-12
Last Posted Date
2019-03-08
Lead Sponsor
Mount Sinai Hospital, Canada
Target Recruit Count
12
Registration Number
NCT01551368
Locations
🇨🇦

Toronto Centre for Advanced reproductive Technology (TCART), Toronto, Ontario, Canada

Monovision for the Treatment of Diplopia

Phase 1
Completed
Conditions
Strabismic Deviation
Interventions
Other: Monovision Correction (with the help of glasses or contact lenses)
First Posted Date
2011-08-31
Last Posted Date
2011-08-31
Lead Sponsor
Mount Sinai Hospital, Canada
Target Recruit Count
20
Registration Number
NCT01426672
Locations
🇨🇦

Edward Margolin, MD, Toronto, Ontario, Canada

Metformin in Women With Type 2 Diabetes in Pregnancy Trial

Phase 3
Completed
Conditions
Type 2 Diabetes
Interventions
Drug: Placebo Comparator
First Posted Date
2011-05-13
Last Posted Date
2020-03-03
Lead Sponsor
Mount Sinai Hospital, Canada
Target Recruit Count
500
Registration Number
NCT01353391
Locations
🇨🇦

The Centre for Mother, Infant, and Child Research, Sunnybrook Research Institute, Toronto, Ontario, Canada

A Randomized Controlled Trial of the Uresta Continence Pessary

Not Applicable
Completed
Conditions
Stress Urinary Incontinence
Interventions
Device: Silastic ring
Device: Uresta pessary
First Posted Date
2011-01-26
Last Posted Date
2017-03-31
Lead Sponsor
Mount Sinai Hospital, Canada
Target Recruit Count
36
Registration Number
NCT01284244
Locations
🇨🇦

Department of Obstetrics and Gynecology, Mount Sinai Hospital, Toronto, Ontario, Canada

Efficacy Study Comparing 2% Chlorhexidine in 70% Isopropyl Alcohol Versus 2% Aqueous Chlorhexidine

Not Applicable
Conditions
Anti-infecting Agents, Local
Interventions
First Posted Date
2011-01-05
Last Posted Date
2013-05-14
Lead Sponsor
Mount Sinai Hospital, Canada
Target Recruit Count
462
Registration Number
NCT01270776
Locations
🇨🇦

Mount Sinai Hospital, Toronto, Ontario, Canada

LIraglutide and Beta-cell RepAir (LIBRA) Study

Phase 3
Completed
Conditions
Type 2 Diabetes
Interventions
Drug: placebo
First Posted Date
2011-01-05
Last Posted Date
2014-09-12
Lead Sponsor
Mount Sinai Hospital, Canada
Target Recruit Count
63
Registration Number
NCT01270789
Locations
🇨🇦

Mount Sinai Hospital, Toronto, Ontario, Canada

Randomized Controlled Trial of Cystocele Plication Risks ("CPR Trial"): A Pilot Study

Phase 2
Completed
Conditions
Voiding Dysfunction
Interventions
Procedure: No Plication
Procedure: Cystocele plication
First Posted Date
2010-09-09
Last Posted Date
2016-12-20
Lead Sponsor
Mount Sinai Hospital, Canada
Target Recruit Count
40
Registration Number
NCT01197248

Effect of Aromatase Inhibitors on Breast Magnetic Resonance Imaging (MRI)

Phase 2
Completed
Conditions
Breast Cancer
Interventions
First Posted Date
2010-05-24
Last Posted Date
2014-05-01
Lead Sponsor
Mount Sinai Hospital, Canada
Target Recruit Count
16
Registration Number
NCT01129622
Locations
🇨🇦

Mount Sinai Hospital, Toronto, Ontario, Canada

Combination Hepatitis A and B Vaccine to Induce Immunity in Non-responders

Phase 4
Withdrawn
Conditions
Hepatitis B
Interventions
Biological: Twinrix
First Posted Date
2010-05-20
Last Posted Date
2020-06-01
Lead Sponsor
Mount Sinai Hospital, Canada
Registration Number
NCT01126853
Locations
🇨🇦

Mount Sinai Hospital, Toronto, Ontario, Canada

Low Level Laser (LED) Use to Increase Dental Implant Stability and Post Operative Analgesia

Not Applicable
Conditions
Implant
Analgesia
Interventions
Device: OsseoPulse device (Light emitting diode technology)
First Posted Date
2010-04-01
Last Posted Date
2010-04-01
Lead Sponsor
Mount Sinai Hospital, Canada
Target Recruit Count
60
Registration Number
NCT01097499
Locations
🇨🇦

Mount Sinai Hospital, Toronto, Ontario, Canada

© Copyright 2025. All Rights Reserved by MedPath